Tag: Abbott

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems. The combination of Abbott’s leading cardiac mapping system with Stereotaxis’ advanced […]

Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People’s Heart Rhythms Long-Term

Abbott’s Assert-IQ offers the world’s longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott’s portfolio of connected health devices, the Assert-IQ ICM offers long-term monitoring and remote programming to improve connectivity to patients The device […]

MEDINBOX PARTNERS WITH ABBOTT TO IMPROVE CONNECTIONS AND INFORMATION SHARING BETWEEN PHYSICIANS IN ELECTROPHYSIOLOGY LABS WORLDWIDE

EnSite™ Connected Care from Abbott will integrate with Medinbox’s smart video collaboration system to provide electrophysiologists with remote, real-time audiovisual support to improve case results Abbott’s exclusive global distribution agreement in electrophysiology market consolidates Medinbox’s position as major player in […]

New Data Show Superiority of Abbott’s TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation

Late-breaking data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine demonstrate TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR) Findings show TriClip, […]

Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott’s MitraClip™ Device

New five-year data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine reinforce the long-term safety and effectiveness of MitraClip for treating secondary mitral regurgitation (MR) Results show minimally invasive mitral valve […]